Search Results - "ALAUPOVIC, P"

Apolipoprotein B–containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis by Knowlton, N., Wages, J. A., Centola, M. B., Giles, J., Bathon, J., Quiroga, C., Alaupovic, P.

“…Objective The purpose of this study was to explore whether nontraditional risk factors, such as apolipoprotein C‐III (Apo C‐III) and its corresponding Apo B…”
Get full text

Apolipoprotein-defined lipoprotein abnormalities in rheumatoid arthritis patients and their potential impact on cardiovascular disease by Knowlton, N, Wages, JA, Centola, MB, Alaupovic, P

“…Objectives: The aim of this study was to explore apolipoprotein-defined lipoproteins for abnormalities when comparing non-rheumatological controls to…”
Get full text

Dual PPAR α/γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia by Samuelsson, O., Attman, P. O., Gause-Nilsson, I., Svensson, M. K., Alaupovic, P.

“…Chronic kidney disease (CKD) is characterised by specific lipoprotein abnormalities and insulin resistance. Dual activation of the peroxisome…”
Get full text

Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency by Samuelsson, O, Mulec, H, Knight-Gibson, C, Attman, P O, Kron, B, Larsson, R, Weiss, L, Wedel, H, Alaupovic, P

“…Chronic renal insufficiency is accompanied by specific alterations of the lipoprotein metabolism. It has been suggested that the renal dyslipoproteinaemia of…”
Get full text

Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency by Alaupovic, P., Attman, P.O., Knight-Gibson, C., Mulec, H., Weiss, L., Samuelsson, O.

“…According to the concept of apolipoprotein (apo)-defined lipoproteins, apoA-I-containing lipoproteins consist of two subclasses referred to as lipoprotein A-I…”
Get full text

Apolipoprotein-B subclasses as acceptors of cholesteryl esters transferred by CETP by Lee, D. M., Alaupovic, P., Knight-Gibson, C., Bagdade, J. D.

“…ABSTRACT Background  Five apolipoprotein (apo)‐defined apoB‐containing lipoprotein (Lp) subclasses designated LpB, LpB:C, LpB:E, LpB:C:E and LpA‐II:B:C:D:E are…”
Get full text

Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound by Blankenhorn, D H, Selzer, R H, Crawford, D W, Barth, J D, Liu, C R, Liu, C H, Mack, W J, Alaupovic, P

“…Controlled clinical trials have reported treatment effects evaluated with serial imaging in coronary and femoral but not cervical arteries. The Cholesterol…”
Get full text

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin by HODIS, H. N, MACK, W. J, AZEN, S. P, ALAUPOVIC, P, POGODA, J. M, LABREE, L, HEMPHILL, L. C, KRAMSCH, D. M, BLANKENHORN, D. H

“…The Monitored Atherosclerosis Regression Study, a randomized, double-blind, placebo-controlled, 2-year trial of lovastatin monotherapy, found that coronary…”
Get full text

The compositional abnormalities of lipoproteins in diabetic renal failure by ATTMAN, P.-O, KNIGHT-GIBSON, C, TAVELLA, M, SAMUELSSON, O, ALAUPOVIC, P

“…Diabetic nephropathy (DN) is a common cause of chronic renal failure (CRF). Patients with DN have abnormal lipoprotein metabolism that can be influenced by…”
Get full text

171 CHARACTERIZATION OF TYPE I AND TYPE II DIABETES BY APOLIPOPROTEIN-DEFINED LIPOPROTEIN SUBCLASSES by Gosmanova, A., Alaupovic, P., Knight-Gibson, C., Lyons, T. J.

“…PurposeThe purpose of this study was to characterize type I and type II diabetes by apolipoprotein-defined apoA-I and apoB-containing lipoprotein…”
Get full text

178 CHARACTERIZATION OF METABOLIC SYNDROME BY APOLIPOPROTEIN-DEFINED LIPOPROTEIN SUBCLASSES by Gosmanova, A., Alaupovic, P., Quiroga, C., Lyons, T. J.

“…PurposeThe purpose of this study was to characterize dyslipidemia of metabolic syndrome by apolipoprotein-defined apoA-I- and apoB-containing lipoprotein…”
Get full text

Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors by Blankenhorn, D H, Alaupovic, P, Wickham, E, Chin, H P, Azen, S P

“…A within-group risk factor analysis was conducted to predict angiographic change in the Cholesterol Lowering Atherosclerosis Study, a randomized,…”
Get full text

Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure by ATTMAN, P.-O, ALAUPOVIC, P, TAVELLA, M, KNIGHT-GIBSON, C

“…To characterize the abnormalities of lipoprotein composition in patients with chronic renal failure (CRF), the lipid and apolipoprotein (apo) concentrations…”
Get full text

Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells by Dashti, N, Williams, D L, Alaupovic, P

“…We have reported previously that, in HepG2 cells, there is a lack of coordinate induction of triglyceride and apolipoprotein (apo) production by oleate and…”
Get full text

Use of Apolipoprotein Parameters and Endpoints in Drug Development and Approval Processes by Alaupovic, Petar

“…Alaupovic identifies apolipoprotein concentrations considered as possible indicators and/or proteins of coronary artery disease risk and recommends a desirable…”
Get full text

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III by Wang, C S, McConathy, W J, Kloer, H U, Alaupovic, P

“…From a total of 22 hypertriglyceridemic subjects tested, 14 subjects were selected on the basis of normal postheparin plasma lipoprotein lipase (LPL) levels…”
Get full text

Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis by Attman, P O, Alaupovic, P

“…To study the effect of renal function on the development of lipid and apolipoprotein abnormalities in human renal disease, we have investigated 75 patients at…”
Get more information

Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency by Bijvoet, S, Gagné, S E, Moorjani, S, Gagné, C, Henderson, H E, Fruchart, J C, Dallongeville, J, Alaupovic, P, Prins, M, Kastelein, J J, Hayden, M R

“…We have assessed the expression of heterozygosity for lipoprotein lipase (LPL) deficiency by studying a single large French Canadian family comprising 92…”
Get full text

Dyslipidemia in peritoneal dialysis--relation to dialytic variables by Johansson, AC, Samuelsson, O, Attman, PO, Haraldsson, B, Moberly, J, Knight-Gibson, C, Alaupovic, P

“…Department of Nephrology, Sahlgrenska University Hospital, Goteborg, Sweden…”
Get full text

Increased production of apolipoprotein B and its lipoproteins by oleic acid in Caco-2 cells by Dashti, N, Smith, EA, Alaupovic, P

“…The production of lipids, apolipoproteins (apo), and lipoproteins induced by oleic acid has been examined in Caco-2 cells. The rates of accumulation in the…”
Get full text